FDA OKs Return of Once-Withdrawn Leukemia Drug

FRIDAY, Sept. 1, 2017 — The U.S. Food and Drug Administration on Friday approved an altered dose of the drug Mylotarg to treat a distinctive type of acute myeloid leukemia — CD33-positive AML.
An earlier version of the drug had been withdrawn from…
Source: Topamax